Celgene

Pharma

Cigna files anti-competition lawsuit against BMS over Pomalyst

Two months after BMS fended off a lawsuit which accused it of using anticompetitive tactics, it is back in court, facing a similar lawsuit from Cigna.

Kevin Dunleavy Jun 25, 2025 8:50am

Court dismisses case against BMS' patent protection of Pomalyst

Apr 9, 2025 11:32am

Merck's Winrevair cuts death, morbidity risk by 76%

Mar 31, 2025 10:00am

BMS skates again on $6.4B Celgene shareholder lawsuit

Oct 1, 2024 10:45am

BMS accused of anticompetitive tactics to keep Pomalyst chugging

Sep 7, 2023 11:31am

BMS does away with the 'old me' in latest Zeposia DTC campaign

Jul 13, 2023 9:25am